Matches in SemOpenAlex for { <https://semopenalex.org/work/W202328241> ?p ?o ?g. }
- W202328241 endingPage "43" @default.
- W202328241 startingPage "38" @default.
- W202328241 abstract "Currently one of the major problems that interventional pulmonologists have to face is the increased proliferation of fibrinous tissue on the site of the stent placement, and usually at the two ends.The drugs rapamycin and pirfenidone were chosen for our experiment. Fibroblasts were also cultured in order to administer pirfenidone and rapamycin in different concentrations. The following cell viability methods were used: (a) Senescence - Cell Titer Assay, (b) Necrosis - Cyto Tox Assay and (c) Apoptosis - Caspase-Glo 3/7 Assay.Rapamycin has minimal to no effect on fibroblasts regarding apoptosis, senescence and necrosis. 0.1 to 1 μM. Pirfenidone concentrations lead to an elevated cell metabolism because cells try to evade the cytotoxic effect of the drug. Increasing Pirfenidone concentrations lead to higher apoptosis rates. 10 μM pirfenidone induces the highest apoptosis rates in this experiment and reduce cell viability to a minimum.Necrosis is unaffected by the investigated drugs." @default.
- W202328241 created "2016-06-24" @default.
- W202328241 creator A5023794918 @default.
- W202328241 creator A5036646589 @default.
- W202328241 creator A5037835689 @default.
- W202328241 creator A5058051428 @default.
- W202328241 creator A5077508524 @default.
- W202328241 creator A5082059315 @default.
- W202328241 creator A5088505116 @default.
- W202328241 date "2014-05-01" @default.
- W202328241 modified "2023-09-23" @default.
- W202328241 title "Cell viability of fibroblasts to pifenidone and sirolimus" @default.
- W202328241 cites W1409723433 @default.
- W202328241 cites W1616716935 @default.
- W202328241 cites W1947703868 @default.
- W202328241 cites W1975756402 @default.
- W202328241 cites W1979301742 @default.
- W202328241 cites W1980332147 @default.
- W202328241 cites W1988486602 @default.
- W202328241 cites W2004800814 @default.
- W202328241 cites W2007260429 @default.
- W202328241 cites W2008030027 @default.
- W202328241 cites W2028253925 @default.
- W202328241 cites W2029181407 @default.
- W202328241 cites W2030181914 @default.
- W202328241 cites W2036417348 @default.
- W202328241 cites W2042637033 @default.
- W202328241 cites W2043766127 @default.
- W202328241 cites W2050903914 @default.
- W202328241 cites W2062248798 @default.
- W202328241 cites W2062387633 @default.
- W202328241 cites W2064711790 @default.
- W202328241 cites W2066398127 @default.
- W202328241 cites W2081831590 @default.
- W202328241 cites W2084012074 @default.
- W202328241 cites W2084753280 @default.
- W202328241 cites W2085604666 @default.
- W202328241 cites W2085843932 @default.
- W202328241 cites W2100098412 @default.
- W202328241 cites W2102803980 @default.
- W202328241 cites W2104016541 @default.
- W202328241 cites W2111693542 @default.
- W202328241 cites W2117295092 @default.
- W202328241 cites W2118360624 @default.
- W202328241 cites W2125639937 @default.
- W202328241 cites W2127039387 @default.
- W202328241 cites W2143772891 @default.
- W202328241 cites W2148810647 @default.
- W202328241 cites W2148955764 @default.
- W202328241 cites W2157051977 @default.
- W202328241 cites W2164191824 @default.
- W202328241 cites W2314326613 @default.
- W202328241 cites W2460133897 @default.
- W202328241 doi "https://doi.org/10.1016/j.ijpharm.2014.03.003" @default.
- W202328241 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24607204" @default.
- W202328241 hasPublicationYear "2014" @default.
- W202328241 type Work @default.
- W202328241 sameAs 202328241 @default.
- W202328241 citedByCount "14" @default.
- W202328241 countsByYear W2023282412014 @default.
- W202328241 countsByYear W2023282412015 @default.
- W202328241 countsByYear W2023282412016 @default.
- W202328241 countsByYear W2023282412017 @default.
- W202328241 countsByYear W2023282412018 @default.
- W202328241 countsByYear W2023282412019 @default.
- W202328241 countsByYear W2023282412020 @default.
- W202328241 countsByYear W2023282412021 @default.
- W202328241 crossrefType "journal-article" @default.
- W202328241 hasAuthorship W202328241A5023794918 @default.
- W202328241 hasAuthorship W202328241A5036646589 @default.
- W202328241 hasAuthorship W202328241A5037835689 @default.
- W202328241 hasAuthorship W202328241A5058051428 @default.
- W202328241 hasAuthorship W202328241A5077508524 @default.
- W202328241 hasAuthorship W202328241A5082059315 @default.
- W202328241 hasAuthorship W202328241A5088505116 @default.
- W202328241 hasConcept C126322002 @default.
- W202328241 hasConcept C142724271 @default.
- W202328241 hasConcept C185592680 @default.
- W202328241 hasConcept C190283241 @default.
- W202328241 hasConcept C2777714996 @default.
- W202328241 hasConcept C2777921159 @default.
- W202328241 hasConcept C2778341716 @default.
- W202328241 hasConcept C2779832356 @default.
- W202328241 hasConcept C503630168 @default.
- W202328241 hasConcept C53227056 @default.
- W202328241 hasConcept C55493867 @default.
- W202328241 hasConcept C62112901 @default.
- W202328241 hasConcept C71924100 @default.
- W202328241 hasConcept C86803240 @default.
- W202328241 hasConcept C98274493 @default.
- W202328241 hasConceptScore W202328241C126322002 @default.
- W202328241 hasConceptScore W202328241C142724271 @default.
- W202328241 hasConceptScore W202328241C185592680 @default.
- W202328241 hasConceptScore W202328241C190283241 @default.
- W202328241 hasConceptScore W202328241C2777714996 @default.
- W202328241 hasConceptScore W202328241C2777921159 @default.
- W202328241 hasConceptScore W202328241C2778341716 @default.
- W202328241 hasConceptScore W202328241C2779832356 @default.